Login
Toggle navigation
Videos
Categories
Trending
Witted Megacorp plans IPO | Joe Sheer, CEO, Witted Megacorp OyjWITTED:HEX
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Joe Sheer is CEO at Witted MegaCorp One.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
working on mission-driven startups with a sustainable social impact|Kasem Rodriguez Mohsen,Founding Partner,Equilibrium Impact Ventures
00:10:00
Downing Renewables & Infrastructure Trust's 2022 Performance: Progress Update by CEO Tom Williams | Tom Williams, CEO , Downing Renewables & Infrastructure Trust PLC.
00:10:00
B2B SaaS & Dev Co Investment Panel|Tom Drummond,Managing Director,Heavybit
00:10:00
Defining Our Core Values: Integrity, Trust, and Communication
00:10:00
Insights from BKW's CEO on his first 100 days, including surprises, priorities, and ambitious goals for the future |Robert Itschner, CEO, BKW AG.
00:10:00
Partnering for Success: Mazzone & Associates and Cherry Bekaert's Collaborative Approach
00:10:00
Brixton Metals Secures Strategic Investment from BHP, Enhances Exploration Potential at Thorn Project
00:00:00
NetScientific PLC actively driving its investee companies forward - Dr. Ilian Iliev CHIEF EXECUTIVE OFFICER, Netscientific
00:10:00
Paving the Way for Mobile Payment and Data Analytics Solutions | Erik Nagel, Chief Executive Officer (CEO) OF UMT United Mobility Technology
00:10:00
Establishing a Strong Financial Plan in 2021: A Post-Pandemic Priority
00:10:00
Navigating Digital Finance with Erik Podzuweit: Insights from the CEO of Scalable Capital
00:10:00
Mod Resources: Exciting Copper Discovery and Pre-Feasibility Progress